The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis

OBJECTIVES: To investigate changes in BMD in RA patients receiving 3-year biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) or conventional synthetic DMARD (csDMARD). METHODS: Patients with RA were recruited from September 2014 until March 2019. Clinical characteristics...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia-Feng, Hsu, Chung-Yuan, Yu, Shan-Fu, Ko, Chi-Hua, Chiu, Wen-Chan, Lai, Han-Ming, Chen, Ying-Chou, Su, Yu-Jih, Cheng, Tien-Tsai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449814/
https://www.ncbi.nlm.nih.gov/pubmed/31984422
http://dx.doi.org/10.1093/rheumatology/kez655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449814/
https://www.ncbi.nlm.nih.gov/pubmed/31984422
http://dx.doi.org/10.1093/rheumatology/kez655

Ejemplares similares